Developer docs
API playgroundTry for free, no card

Search company profiles

Agmedica Bioscience

Full company profile

uuid000a27n

Namestring
Agmedica Bioscience
Legal namestring
AgMedica Bioscience Inc.
Websiteurl
agmedica.ca
Company typeenum
Private
Founded yearint
2014
Descriptiontext

AgMedica Bioscience Inc. is a Canadian licensed producer of cannabis, headquartered in Chatham, Ontario, operating a custom-designed 80,000 square foot indoor cultivation facility built around a proprietary vertical-tier grow architecture that the company states yields meaningfully higher biomass per square foot than conventional single-tier indoor layouts. Cultivation relies on LED lighting, a master-grower-designed custom fertigation system that reduces water use and eliminates fertilizer runoff, and biological pest control using beneficial insects rather than chemical interventions; all flower is hand-sorted, hand-finished, and hand-packed into foil-sealed containers with humidity-control packs. The company holds Health Canada licenses for cultivation, processing, and medical sales, GACP certification, IMC-GAP certification under the Israeli Medical Cannabis Agency, and EU GMP certification for both dried flower and cannabis extracts, which together permit pharmaceutical-grade exports to the European Union and Israel.

The product portfolio consists of dried flower (including Cold Creek Kush and Strawberry Cake strains) and a line of cannabis oil drops formulated in olive oil carrier across four ratios: 30:1 high-THC, 15:24 balanced, 1:20 high-CBD, and 4:100 very-high-CBD, all distributed under the Vertical Cannabis brand umbrella with Medical, Recreational, and Value sub-brand tiers. The business model is direct-to-consumer via the shop.agmedica.ca e-commerce platform to registered Canadian medical cannabis patients, supplemented by adult-use recreational sales and international wholesale export of EU GMP certified product; pricing is unit-based with eight distinct discount programs targeting veterans, seniors, first responders, healthcare providers, caregivers, motor vehicle accident victims, compassionate-care patients, and renewals. Since the 2025 acquisition by Decibel Cannabis Company Inc., AgMedica operates as a subsidiary contributing $7.6M in Q4 2025 revenue and serving as the regulatory and production engine behind Decibel's 484% growth in international sales to $24M for full-year 2025.

Short descriptiontext

AgMedica Bioscience Inc. is a Canadian licensed cannabis producer operating an 80,000 sq ft vertical-tier indoor facility in Chatham, Ontario, supplying pharmaceutical-grade dried flower and cannabis oils to Canadian medical patients, recreational consumers, and EU/Israel export markets under the Vertical Cannabis brand.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersChatham, Canada
HQ citystring
Chatham
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
licensed cannabis producer, medical cannabis cultivation, pharmaceutical-grade cannabis, cannabis oil extracts, EU GMP certified cannabis
Industry3 codes
PRIMARYCRANAFAB
Medical Cannabis Dispensaries
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
SECONDARYCRANAFAG
Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
SECONDARYCRANAFAH
Cannabis Dispensary + Ancillary Retail (Accessories, CBD/Hemp, Merchandise)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
NAICS code2 codes
  • Medicinal and Botanical Manufacturing325411
  • All Other Health and Personal Care Retailers456199
SIC code2 codes
  • Retail-Drug Stores And Proprietary Stores5912
  • Medicinal Chemicals & Botanical Products2833
Product category
Licensed Medical Cannabis Production
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Cannabis Product Sales
TypeOne Time License
Description

Direct sales of medical cannabis products including dried flower, milled flower, and cannabis oils to registered medical patients in Canada through the company's e-commerce platform.

agmedica.ca
2Adult-Use/Recreational Sales
TypeOne Time License
Description

Sales of recreational cannabis products through brand portfolio including Medical, Recreational, and Value tiers.

stocktitan.net
3International Export
TypeOne Time License
Description

Export of EU GMP certified pharmaceutical grade medical cannabis to international markets including the European Union and Israel.

agmedica.ca
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Pricing details8 tiers
1Standard Dried Flower - Cold Creek Kush
ModelUnit PricingBilling cadencePay-as-you-go
Notes

5g: $39.95 | 10g: $79.90 | 15g: $119.85 | THC: 20-26%

agmedica.ca
2Standard Cannabis Oils
ModelUnit PricingBilling cadencePay-as-you-go
Notes

30:1 THC Drops 30ml: $39.99 | 15:24 Balanced Drops 30ml: $49.99 | 4:100 CBD Drops 30ml: $99.99

agmedica.ca
3Compassionate Care Program
ModelUnit PricingBilling cadencePay-as-you-go
Notes

30% off first order plus 25% off all subsequent orders. For patients earning $35,000 or under annually or on disability/government subsidy programs.

agmedica.ca
4First Time Order
ModelUnit PricingBilling cadencePay-as-you-go
Notes

30% off first order for all new patients.

agmedica.ca
5Seniors Program
ModelUnit PricingBilling cadencePay-as-you-go
Notes

30% off first order plus 20% off all subsequent orders. For patients aged 60+.

agmedica.ca
6Veterans Program
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Company pays difference for anything above $8.50/gram (Veterans Affairs Canada reimbursement limit).

agmedica.ca
7Renewal Discount
ModelUnit PricingBilling cadencePay-as-you-go
Notes

15% off first order on new prescription for existing patients.

agmedica.ca
8Motor Vehicle Accident Program
ModelUnit PricingBilling cadencePay-as-you-go
Notes

30% off first order plus 20% off all orders plus free shipping. For clients injured in motor vehicle accidents.

agmedica.ca
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Agmedica Bioscience is a Canadian licensed producer (Health Canada) that cultivates and processes pharmaceutical-grade cannabis at an 80,000 sq ft indoor vertical-tier facility in Chatham, Ontario. It sells a portfolio of dried flower strains (e.g., Cold Creek Kush, Strawberry Cake) and four cannabis oil formulations (30:1 THC, 15:24 Balanced, 1:20 CBD, 4:100 CBD) direct-to-consumer to registered Canadian medical patients via shop.agmedica.ca, with EU GMP certified exports to the EU and Israel and additional Adult-Use/Recreational and Value brands.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Q4 2025 revenue contribution of $7.6M to parent company
+1 more record
Product overview1 text field

AgMedica Bioscience Inc. is a Canadian licensed producer of cannabis offering a portfolio of premium medical cannabis products sold directly to patients through their online shop. The product portfolio centers on two main categories: dried flower products (including Cold Creek Kush and Strawberry Cake strains with varying THC/CBD profiles) and cannabis oil drops (featuring four formulations ranging from high-THC 30:1 drops to very high-CBD 4:100 drops, all using premium olive oil as a carrier). Products are marketed under the Vertical Cannabis brand umbrella, with sub-brands serving medical, recreational, and value market segments. The company operates vertically integrated cultivation and processing facilities, hand-harvesting and hand-finishing all products to ensure quality.

Product and service8 records
1Cold Creek Kush (Dried Flower)
CategoryDried Flower Cannabis
Description

Premium Indica-dominant dried flower cannabis strain (MK Ultra x Chemdawg 91), THC 20-26%, CBD <1%, dominant terpenes Beta-Myrcene, Beta-Ocimene, Beta-Caryophyllene; sold to registered Canadian medical cannabis patients and recreational consumers.

2Strawberry Cake (Dried Flower)
CategoryDried Flower Cannabis
Description

Premium dried flower cannabis strain bred from Chronic x White Widow x Cheese, sold to registered Canadian medical cannabis patients and recreational consumers.

330:1 THC Drops (Cannabis Oil)
CategoryCannabis Oil
Description

High-potency THC cannabis oil drops (THC 28-32 mg/ml, CBD <1 mg/ml), 30ml bottle for $39.99, extracted from indoor-grown cannabis using a premium olive oil carrier; for medical patients seeking high-THC formulations.

415:24 Balanced Drops (Cannabis Oil)
CategoryCannabis Oil
Description

Balanced THC/CBD cannabis oil drops (THC 15-18 mg/ml, CBD 23-26 mg/ml), 30ml bottle for $49.99, extracted from indoor-grown cannabis with premium olive oil carrier; for medical patients seeking a balanced formulation.

51:20 CBD Drops (Cannabis Oil)
CategoryCannabis Oil
Description

High-CBD cannabis oil drops (THC <1 mg/ml, CBD 20-24 mg/ml), targeted at medical patients seeking non-psychoactive CBD options.

64:100 CBD Drops (Cannabis Oil)
CategoryCannabis Oil
Description

Very high-CBD cannabis oil drops (THC 4-6 mg/ml, CBD 100-108 mg/ml), 30ml bottle for $99.99, designed for medical patients requiring very high CBD levels.

7Milled Flower
CategoryDried Flower Cannabis
Description

Milled cannabis flower product listed by AgMedica for registered medical cannabis patients in Canada.

8Vertical Cannabis Brand Portfolio (Medical / Recreational / Value)
CategoryCannabis Brand Portfolio
Description

Vertically Cannabis-branded portfolio of cannabis products across three market tiers (Medical, Recreational, and Value) targeting pharma-grade medical patients, adult-use consumers, and value-oriented buyers respectively.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AgMedica's parent company and primary Canadian recreational/medical cannabis operator; AgMedica is integrated into Decibel's portfolio and distribution network, making Decibel the most directly comparable peer in cultivation, brand portfolio structure, and Canadian market exposure.

2Tilray Brands
TypeBroad incumbent
Description

One of Canada's largest licensed producers with EU GMP-certified medical cannabis operations and significant international footprint. Comparable in pharma-grade medical positioning and global export ambitions, though far larger and more diversified across alcohol and wellness.

TypeBroad incumbent
Description

Largest Canadian LP by historical scale with multiple cultivation facilities, multi-brand portfolio, and established medical cannabis programs. Comparable in regulated cannabis production and patient-direct models, though operating at significantly greater scale and capital intensity.

TypeBroad incumbent
Description

Canadian licensed producer with EU GMP-certified facilities and active international medical cannabis distribution, particularly in Europe. Comparable in EU GMP positioning, medical-channel focus, and European export orientation.

TypeDirect peer
Description

Canadian LP focused on premium indoor cultivation and a multi-brand portfolio across medical and recreational segments. Comparable in indoor cultivation methodology, tiered branding strategy, and patient-direct medical sales.

TypeBroad incumbent
Description

Canadian licensed producer with established international medical cannabis operations and a focus on premium product quality. Comparable in regulated cannabis cultivation and global medical export focus.

TypeDirect peer
Description

Canadian cannabis company specializing in pharmaceutical-grade extraction and EU GMP-certified cannabis APIs. Comparable as a pharma-grade cannabis manufacturer focused on extracts rather than flower, sharing the EU GMP and international B2B medical channel.

8Aleafia Health (now Entourage Health)
TypeDirect peer
Description

Canadian LP with a vertically integrated medical cannabis platform including patient-direct e-commerce and chronic pain/clinical indications focus. Comparable in DTC medical model and emphasis on patient programs.

TypeBroad incumbent
Description

Canadian-controlled greenhouse grower with cannabis subsidiary (Pure Sunfarms) producing at scale for the recreational and medical markets. Comparable as a Canadian indoor/greenhouse cannabis producer though at significantly larger scale and with a different cultivation methodology.

TypeDirect peer
Description

Canadian LP with established medical and recreational brands and DTC e-commerce. Comparable in multi-tier brand portfolio approach and direct-to-patient medical sales, though operating under more severe capital constraints.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment8 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Agmedica Bioscience

Licensed Medical Cannabis Productionagmedica.ca

AgMedica Bioscience Inc. is a Canadian licensed cannabis producer operating an 80,000 sq ft vertical-tier indoor facility in Chatham, Ontario, supplying pharmaceutical-grade dried flower and cannabis oils to Canadian medical patients, recreational consumers, and EU/Israel export markets under the Vertical Cannabis brand.

What Agmedica Bioscience does

AgMedica Bioscience Inc. is a Canadian licensed producer of cannabis, headquartered in Chatham, Ontario, operating a custom-designed 80,000 square foot indoor cultivation facility built around a proprietary vertical-tier grow architecture that the company states yields meaningfully higher biomass per square foot than conventional single-tier indoor layouts. Cultivation relies on LED lighting, a master-grower-designed custom fertigation system that reduces water use and eliminates fertilizer runoff, and biological pest control using beneficial insects rather than chemical interventions; all flower is hand-sorted, hand-finished, and hand-packed into foil-sealed containers with humidity-control packs. The company holds Health Canada licenses for cultivation, processing, and medical sales, GACP certification, IMC-GAP certification under the Israeli Medical Cannabis Agency, and EU GMP certification for both dried flower and cannabis extracts, which together permit pharmaceutical-grade exports to the European Union and Israel.

The product portfolio consists of dried flower (including Cold Creek Kush and Strawberry Cake strains) and a line of cannabis oil drops formulated in olive oil carrier across four ratios: 30:1 high-THC, 15:24 balanced, 1:20 high-CBD, and 4:100 very-high-CBD, all distributed under the Vertical Cannabis brand umbrella with Medical, Recreational, and Value sub-brand tiers. The business model is direct-to-consumer via the shop.agmedica.ca e-commerce platform to registered Canadian medical cannabis patients, supplemented by adult-use recreational sales and international wholesale export of EU GMP certified product; pricing is unit-based with eight distinct discount programs targeting veterans, seniors, first responders, healthcare providers, caregivers, motor vehicle accident victims, compassionate-care patients, and renewals. Since the 2025 acquisition by Decibel Cannabis Company Inc., AgMedica operates as a subsidiary contributing $7.6M in Q4 2025 revenue and serving as the regulatory and production engine behind Decibel's 484% growth in international sales to $24M for full-year 2025.

Agmedica Bioscience firmographics

Firmographics
Name
Agmedica Bioscience
Legal name
AgMedica Bioscience Inc.
Website
https://agmedica.ca
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
AgMedica Bioscience Inc. is a Canadian licensed cannabis producer operating an 80,000 sq ft vertical-tier indoor facility in Chatham, Ontario, supplying pharmaceutical-grade dried flower and cannabis oils to Canadian medical patients, recreational consumers, and EU/Israel export markets under the Vertical Cannabis brand.
Ownership category
akta.pro rank

Agmedica Bioscience industry classification

Industry
Product category
Licensed Medical Cannabis Production
NAICS
Medicinal and Botanical Manufacturing (325411), All Other Health and Personal Care Retailers (456199)
SIC
Retail-Drug Stores And Proprietary Stores (5912), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYCRANAFAB
Medical Cannabis Dispensaries
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
SECONDARYCRANAFAG
Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
SECONDARYCRANAFAH
Cannabis Dispensary + Ancillary Retail (Accessories, CBD/Hemp, Merchandise)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)

Keywords

  • Licensed cannabis producer
  • Medical cannabis cultivation
  • Pharmaceutical-grade cannabis
  • Cannabis oil extracts
  • EU GMP certified cannabis

Where Agmedica Bioscience is headquartered

Location

Headquarters

HQ city
Chatham
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Agmedica Bioscience business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Medical Cannabis Product Sales: Direct sales of medical cannabis products including dried flower, milled flower, and cannabis oils to registered medical patients in Canada through the company's e-commerce platform.
  2. Adult-Use/Recreational Sales: Sales of recreational cannabis products through brand portfolio including Medical, Recreational, and Value tiers.
  3. International Export: Export of EU GMP certified pharmaceutical grade medical cannabis to international markets including the European Union and Israel.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard Dried Flower - Cold Creek Kush
Unit PricingPay-as-you-goStandard Cannabis Oils
Unit PricingPay-as-you-goCompassionate Care Program
Unit PricingPay-as-you-goFirst Time Order
Unit PricingPay-as-you-goSeniors Program
Unit PricingPay-as-you-goVeterans Program
Unit PricingPay-as-you-goRenewal Discount
Unit PricingPay-as-you-goMotor Vehicle Accident Program

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Agmedica Bioscience product offering

Product offering

Core offering

Agmedica Bioscience is a Canadian licensed producer (Health Canada) that cultivates and processes pharmaceutical-grade cannabis at an 80,000 sq ft indoor vertical-tier facility in Chatham, Ontario. It sells a portfolio of dried flower strains (e.g., Cold Creek Kush, Strawberry Cake) and four cannabis oil formulations (30:1 THC, 15:24 Balanced, 1:20 CBD, 4:100 CBD) direct-to-consumer to registered Canadian medical patients via shop.agmedica.ca, with EU GMP certified exports to the EU and Israel and additional Adult-Use/Recreational and Value brands.

Product overview

AgMedica Bioscience Inc. is a Canadian licensed producer of cannabis offering a portfolio of premium medical cannabis products sold directly to patients through their online shop. The product portfolio centers on two main categories: dried flower products (including Cold Creek Kush and Strawberry Cake strains with varying THC/CBD profiles) and cannabis oil drops (featuring four formulations ranging from high-THC 30:1 drops to very high-CBD 4:100 drops, all using premium olive oil as a carrier). Products are marketed under the Vertical Cannabis brand umbrella, with sub-brands serving medical, recreational, and value market segments. The company operates vertically integrated cultivation and processing facilities, hand-harvesting and hand-finishing all products to ensure quality.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cold Creek Kush (Dried Flower) Premium Indica-dominant dried flower cannabis strain (MK Ultra x Chemdawg 91), THC 20-26%, CBD <1%, dominant terpenes Beta-Myrcene, Beta-Ocimene, Beta-Caryophyllene; sold to registered Canadian medical cannabis patients and recreational consumers.
  • Strawberry Cake (Dried Flower) Premium dried flower cannabis strain bred from Chronic x White Widow x Cheese, sold to registered Canadian medical cannabis patients and recreational consumers.
  • 30:1 THC Drops (Cannabis Oil) High-potency THC cannabis oil drops (THC 28-32 mg/ml, CBD <1 mg/ml), 30ml bottle for $39.99, extracted from indoor-grown cannabis using a premium olive oil carrier; for medical patients seeking high-THC formulations.
  • 15:24 Balanced Drops (Cannabis Oil) Balanced THC/CBD cannabis oil drops (THC 15-18 mg/ml, CBD 23-26 mg/ml), 30ml bottle for $49.99, extracted from indoor-grown cannabis with premium olive oil carrier; for medical patients seeking a balanced formulation.
  • 1:20 CBD Drops (Cannabis Oil) High-CBD cannabis oil drops (THC <1 mg/ml, CBD 20-24 mg/ml), targeted at medical patients seeking non-psychoactive CBD options.
  • 4:100 CBD Drops (Cannabis Oil) Very high-CBD cannabis oil drops (THC 4-6 mg/ml, CBD 100-108 mg/ml), 30ml bottle for $99.99, designed for medical patients requiring very high CBD levels.
  • Milled Flower Milled cannabis flower product listed by AgMedica for registered medical cannabis patients in Canada.
  • Vertical Cannabis Brand Portfolio (Medical / Recreational / Value) Vertically Cannabis-branded portfolio of cannabis products across three market tiers (Medical, Recreational, and Value) targeting pharma-grade medical patients, adult-use consumers, and value-oriented buyers respectively.

Quantifiable outcome

  • Q4 2025 revenue contribution of $7.6M to parent company
  • +1 more outcomes

Companies that use Agmedica Bioscience

Customer profile

Named customers1 record

Segments8 records

Ideal customer profiles2 records

Agmedica Bioscience technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Agmedica Bioscience partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Agmedica Bioscience competitors and assessment

Company assessment

Direct peers

  • Decibel Cannabis Company Inc. AgMedica's parent company and primary Canadian recreational/medical cannabis operator; AgMedica is integrated into Decibel's portfolio and distribution network, making Decibel the most directly comparable peer in cultivation, brand portfolio structure, and Canadian market exposure.
  • OrganiGram Holdings: Canadian LP focused on premium indoor cultivation and a multi-brand portfolio across medical and recreational segments. Comparable in indoor cultivation methodology, tiered branding strategy, and patient-direct medical sales.
  • MediPharm Labs Corp. Canadian cannabis company specializing in pharmaceutical-grade extraction and EU GMP-certified cannabis APIs. Comparable as a pharma-grade cannabis manufacturer focused on extracts rather than flower, sharing the EU GMP and international B2B medical channel.
  • Aleafia Health (now Entourage Health): Canadian LP with a vertically integrated medical cannabis platform including patient-direct e-commerce and chronic pain/clinical indications focus. Comparable in DTC medical model and emphasis on patient programs.
  • Hexo Corp: Canadian LP with established medical and recreational brands and DTC e-commerce. Comparable in multi-tier brand portfolio approach and direct-to-patient medical sales, though operating under more severe capital constraints.

Broad incumbents

  • Tilray Brands: One of Canada's largest licensed producers with EU GMP-certified medical cannabis operations and significant international footprint. Comparable in pharma-grade medical positioning and global export ambitions, though far larger and more diversified across alcohol and wellness.
  • Canopy Growth Corporation: Largest Canadian LP by historical scale with multiple cultivation facilities, multi-brand portfolio, and established medical cannabis programs. Comparable in regulated cannabis production and patient-direct models, though operating at significantly greater scale and capital intensity.
  • Aurora Cannabis Inc. Canadian licensed producer with EU GMP-certified facilities and active international medical cannabis distribution, particularly in Europe. Comparable in EU GMP positioning, medical-channel focus, and European export orientation.
  • Cronos Group: Canadian licensed producer with established international medical cannabis operations and a focus on premium product quality. Comparable in regulated cannabis cultivation and global medical export focus.
  • Village Farms International: Canadian-controlled greenhouse grower with cannabis subsidiary (Pure Sunfarms) producing at scale for the recreational and medical markets. Comparable as a Canadian indoor/greenhouse cannabis producer though at significantly larger scale and with a different cultivation methodology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Agmedica Bioscience social profiles

Digital presence

Agmedica Bioscience compliance and trust

Trust signal

Compliance4 records

Agmedica Bioscience financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Agmedica Bioscience leadership team

Management profile

Number of profiles

Profiles1 record

Agmedica Bioscience funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Agmedica Bioscience M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Agmedica Bioscience

What does Agmedica Bioscience do?

Agmedica Bioscience is a Canadian licensed producer (Health Canada) that cultivates and processes pharmaceutical-grade cannabis at an 80,000 sq ft indoor vertical-tier facility in Chatham, Ontario. It sells a portfolio of dried flower strains (e.g., Cold Creek Kush, Strawberry Cake) and four cannabis oil formulations (30:1 THC, 15:24 Balanced, 1:20 CBD, 4:100 CBD) direct-to-consumer to registered Canadian medical patients via shop.agmedica.ca, with EU GMP certified exports to the EU and Israel and additional Adult-Use/Recreational and Value brands.

Is Agmedica Bioscience a public or private company?

Agmedica Bioscience is a private company. It is classified as corporate owned and is currently operating.

When was Agmedica Bioscience founded?

Agmedica Bioscience was founded in 2014. It employs 11 to 50 people.

Where is Agmedica Bioscience based?

Agmedica Bioscience is headquartered in Chatham, Canada, in the North America region.

How does Agmedica Bioscience make money?

Three revenue lines are on record. Medical Cannabis Product Sales are the primary driver. The others are adult-Use/Recreational Sales and international Export.

Who are Agmedica Bioscience's main competitors?

Direct peers on record are Decibel Cannabis Company Inc., OrganiGram Holdings, MediPharm Labs Corp., Aleafia Health (now Entourage Health) and Hexo Corp. Broad incumbents are Tilray Brands, Canopy Growth Corporation, Aurora Cannabis Inc., Cronos Group and Village Farms International.

Does Agmedica Bioscience have an API?

No public API is recorded for Agmedica Bioscience.

What industry is Agmedica Bioscience in?

Agmedica Bioscience's product category is Licensed Medical Cannabis Production. Its primary akta.pro industry code is CRANAFAB, Medical Cannabis Dispensaries, with a secondary code of CRANAFAG, Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail). Its NAICS code is 325411 and its SIC code is 5912.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Stock TitanDecibel 2025 revenue rises 22%, sees $130M-$135MDecibel Cannabis Company Inc. reported full-year 2025 revenue of $113 million, a 22% increase year-over-year, driven by strong international sales growth of 484% to $24 million and the successful integration of the AgMedica Bioscience acquisition, which contributed $7.6 million in Q4 2025 revenue. The company issued 2026 guidance of $130–135 million in net revenue and announced it closed a new $61 million credit facility extending debt maturities to 2030, while also selling its Creston, British Columbia cultivation property for $2.5 million. Decibel CEO Benjamin Sze attributed the performance to 3x growth in free cash flow and international expansion, with domestic sales growth constrained to under 1% due to competitive dynamics and a BC Liquor Distribution Branch strike.PR NewswireDecibel Delivers Strong Revenue Growth and Profitability in Second QuarterDecibel Cannabis Company Inc. reported strong Q2 2025 financial results with net revenue of $29.8 million, representing a 35% year-over-year increase driven by contributions from the acquired AgMedica Bioscience Inc. International sales surged to $6.1 million from $37,000 in Q2 2024, while adjusted EBITDA rose 60% to $6.3 million. The company achieved free cash flow of $2.2 million compared to negative $2.1 million in the prior year period, reflecting successful integration of AgMedica and expanding global market presence.NewswireDecibel Announces TSX Venture Exchange Acceptance for AgMedica Acquisition and Debenture ConversionDecibel Cannabis Company Inc. has received final acceptance from the TSX Venture Exchange for its acquisition of AgMedica Bioscience Inc., which was announced on October 28, 2024. This acquisition involved a $6.3 million unsecured convertible debenture, resulting in Decibel issuing 114,545,455 common shares to Callisto Capital Corp. upon conversion of the debenture. Additionally, Callisto will not be considered a Control Person of Decibel following this conversion.GlobeNewswireAtlas Global Brands Inc. (formerly Silver Phoenix Resources Inc.) Completes RTO with Atlas Growers Ltd., AgMedica Bioscience Inc. and Cambrosia Ltd.; Set to Commence Trading on the Canadian SecuritiesAtlas Global Brands completed a reverse take-over with Atlas Growers, AgMedica, and Cambrosia, forming a fully integrated cannabis company. The combined entity operates in Canada and Israel, with trading on the Canadian Securities Exchange expected on January 13, 2023 under the ticker 'ATL'.GlobeNewswireAgMedica Bioscience Inc. Announces Receipt of Cannabis OilAgMedica Bioscience received Health Canada approval for a cannabis oil sales license effective May 31, 2019, enabling CBD, THC, and Balanced oil products. The company will use its Bio-Herbolysis extraction technology, which offers cost advantages, and plans larger-scale processing equipment later in 2019.GlobeNewswireAgMedica Bioscience Inc. Announces Closing of Strategic Investment in Extraction Technology Company, Herbolea Biotech S.r.l.AgMedica Bioscience closed a strategic investment in Herbolea Biotech, an Italian extraction technology firm, and secured exclusive rights to use Bio-Herbolysis in Canada and Germany. AgMedica holds a 25% equity stake and will appoint a board member. The company plans to deploy the technology in its Canadian operations in Q1 2019.MjbizdailyTissue CultureCannabis cultivators are increasingly adopting tissue culture, a sterile micropropagation method, to replace traditional cloning for more efficient plant production and superior genetic preservation. Major industry players such as Canopy Growth, AgMedica Bioscience, and Front Range BioSciences are implementing this technology to scale operations or supply nurseries, driven by advantages in space efficiency and yield volume.